| scholarly article | Q13442814 |
| P50 | author | Karen L Kotloff | Q63214788 |
| P2093 | author name string | Wilbur H Chen | |
| P2860 | cites work | Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era | Q22253018 |
| Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study | Q30275836 | ||
| Association Between Shigella Infection and Diarrhea Varies Based on Location and Age of Children | Q30278777 | ||
| Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). | Q30278967 | ||
| Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoid | Q33607442 | ||
| Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602 | Q33876803 | ||
| Strategy for cross-protection among Shigella flexneri serotypes | Q34000330 | ||
| Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel | Q34006223 | ||
| Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans | Q34068059 | ||
| Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults | Q34120926 | ||
| Shigella isolates from the global enteric multicenter study inform vaccine development | Q34202171 | ||
| Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study | Q34345075 | ||
| Status of vaccine research and development for Shigella | Q34518265 | ||
| Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial | Q34673466 | ||
| Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers | Q35523144 | ||
| South Asia as a Reservoir for the Global Spread of Ciprofloxacin-Resistant Shigella sonnei: A Cross-Sectional Study | Q36092436 | ||
| Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains | Q36720620 | ||
| Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects | Q36764372 | ||
| Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road | Q36844719 | ||
| Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a. | Q36920244 | ||
| Parenteral Vaccination Can Be an Effective Means of Inducing Protective Mucosal Responses | Q36973944 | ||
| Circulating Gut-Homing (α4β7+) Plasmablast Responses against Shigella Surface Protein Antigens among Hospitalized Patients with Diarrhea | Q37067264 | ||
| Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults | Q37067290 | ||
| Progress and pitfalls in Shigella vaccine research | Q37105553 | ||
| Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study. | Q37477196 | ||
| Inactivated and subunit vaccines to prevent shigellosis | Q37640115 | ||
| Polysaccharide-protein conjugates: a new generation of vaccines | Q37914157 | ||
| Recent progress towards development of a Shigella vaccine | Q38068954 | ||
| The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance. | Q38100050 | ||
| An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children | Q38284501 | ||
| Characterization of a multicomponent live, attenuated Shigella flexneri vaccine | Q38776163 | ||
| Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis | Q39119101 | ||
| Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. | Q39146446 | ||
| Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile | Q39252440 | ||
| Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis | Q40211202 | ||
| Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum | Q40538332 | ||
| Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children | Q40552513 | ||
| Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2 | Q40687041 | ||
| Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering Escherichia coli | Q41008205 | ||
| Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial | Q42982958 | ||
| Recommendations regarding the development of combined enterotoxigenic Eschericha coli and Shigella vaccines for infants | Q48669093 | ||
| Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. | Q50464343 | ||
| Safety, dose, immunogenicity, and transmissibility of an oral live attenuated Shigella flexneri 2a vaccine candidate (SC602) among healthy adults and school children in Matlab, Bangladesh. | Q51745561 | ||
| Live oral Shigella vaccine: vaccination schedule and the effect of booster dose. | Q54362925 | ||
| Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. | Q54572055 | ||
| Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children. | Q64948328 | ||
| Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine | Q68043029 | ||
| Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population | Q68134308 | ||
| Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children | Q77399559 | ||
| Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media | Q81445405 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 904-907 | |
| P577 | publication date | 2016-10-05 | |
| P1433 | published in | Clinical and Vaccine Immunology | Q5133811 |
| P1476 | title | Shigella Vaccine Development: Finding the Path of Least Resistance | |
| P478 | volume | 23 |
| Q49210830 | A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country |
| Q64996406 | A murine model of diarrhea, growth impairment and metabolic disturbances with Shigella flexneri infection and the role of zinc deficiency. |
| Q92801042 | Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate |
| Q99616537 | Establishment of a Controlled Human Infection Model with a Lyophilized Strain of Shigella sonnei 53G |
| Q90441881 | Increasing the affinity of an O-antigen polysaccharide binding site in Shigella flexneri bacteriophage Sf6 tailspike protein |
Search more.